Search

Author/Creator Spickermann, Jochen

1. Prediction of Safety Margin and Optimization of Dosing Protocol for a Novel Antibiotic using Quantitative Systems Pharmacology Modeling. Issue 5 (7th June 2018)

Authors:
Woodhead, Jeffrey L.; Paech, Franziska; Maurer, Martina; Engelhardt, Marc; Schmitt‐Hoffmann, Anne H.; Spickermann, Jochen; Messner, Simon; Wind, Mathias; Witschi, Anne‐Therese; Krähenbühl, Stephan; Siler, Scott Q.; Watkins, Paul B.; Howell, Brett A.
Journal:
Clinical and translational science
Issue:
Volume 11:Issue 5(2018)
Page Start:
498
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The fibroblast growth factor receptor inhibitor, derazantinib, has strong efficacy in human gastric tumor models and synergizes with paclitaxel in vivo. Issue 4 (2nd April 2023)

Authors:
McSheehy, Paul M.J.; Forster-Gross, Nicole; El Shemerly, Mahmoud; Bachmann, Felix; Roceri, Mila; Hermann, Norbert; Spickermann, Jochen; Kellenberger, Laurenz; Lane, Heidi A.
Journal:
Anti-cancer drugs
Issue:
Volume 34:Issue 4(2023)
Page Start:
532
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search